Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

OLYMPUS Aktie

 >OLYMPUS Aktienkurs 
8.614 EUR    +0.7%    (TradegateBSX)
Ask: 8.618 EUR / 587 Stück
Bid: 8.492 EUR / 596 Stück
Tagesumsatz: 1744 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
OLYMPUS Aktie über LYNX handeln
>OLYMPUS Performance
1 Woche: +6,2%
1 Monat: +14,0%
3 Monate: -20,1%
6 Monate: -19,7%
1 Jahr: -23,6%
laufendes Jahr: -20,6%
>OLYMPUS Aktie
Name:  OLYMPUS CORP.
Land:  Japan
Sektor:  Gesundheit
ISIN/ Wkn:  JP3201200007 / 856840
Symbol/ Ticker:  OLY1 (Frankfurt)
Kürzel:  FRA:OLY1, ETR:OLY1, OLY1:GR
Index:  Nikkei225
Webseite:  https://www.olympus-globa..
Profil:  Olympus Corporation is a multinational company known for its advancements in optics, imaging, and medical technology. Originally established in Japan in 1919, Olympus has grown to become a dominant player in the medical systems sector, particularly i..
>Volltext..
Marktkapitalisierung:  9351.98 Mio. EUR
Unternehmenswert:  9575.06 Mio. EUR
Umsatz:  5458.89 Mio. EUR
EBITDA:  1224.9 Mio. EUR
Nettogewinn:  468.93 Mio. EUR
Gewinn je Aktie:  0.42 EUR
Schulden:  1314.66 Mio. EUR
Liquide Mittel:  936.79 Mio. EUR
Operativer Cashflow:  682.7 Mio. EUR
Bargeldquote:  0.49
Umsatzwachstum:  -11.41%
Gewinnwachstum:  -10.42%
Dividende je Aktie:  0.16 EUR
Dividendenrendite:  1.31%
Dividendenschätzung:  2%
Div. Historie:  30.03.26 - 0.16381112€
28.03.25 - 0.113952€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  OLYMPUS
Letzte Datenerhebung:  03.04.26
>OLYMPUS Kennzahlen
Aktien/ Unternehmen:
Aktien: 1101.07 Mio. St.
Frei handelbar: 92.51%
Leerverk. Aktien: -
Rückkaufquote: 2.96%
Mitarbeiter: 29297
Umsatz/Mitarb.: 0.2 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 16.83%
Bewertung:
KGV: 20.81
KGV lG: 28.2
KUV: 1.67
KBV: 2.23
PEG-Ratio: 5.51
EV/EBITDA: 7.82
Rentabilität:
Bruttomarge: 66.24%
Gewinnmarge: 8.59%
Operative Marge: 15.56%
Managementeffizenz:
Gesamtkaprendite: 5.92%
Eigenkaprendite: 11.25%
 >OLYMPUS Anleihen 
>OLYMPUS Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
02.04.26 - 20:03
OLYMPUS PROPERTY LAUNCHES MID-ATLANTIC EXPANSION WITH ASCEND BY THE SEA (PR Newswire)
 
FORT WORTH, Texas, April 2, 2026 /PRNewswire/ -- Olympus Property has acquired Ascend by the Sea, a newly constructed 216-unit Class A luxury apartment community located in Millville, Delaware—along Southern Delaware's popular Beaches corridor. This marks Olympus' first asset in the......
01.04.26 - 20:42
Olympus Partners Decides the Thyme is Right, Invests in Vesta Foodservice (PR Newswire)
 
Strategic Partnership to Scale Leading Specialty Food Distribution Platform STAMFORD, Conn., April 1, 2026 /PRNewswire/ -- Olympus Partners ("Olympus") today announced a strategic investment in Vesta Foodservice ("Vesta"), a premier specialty foodservice distribution company primarily......
01.04.26 - 15:16
Olympus Corporation of the Americas Announces Leadership Change (PR Newswire)
 
CENTER VALLEY, Pa., April 1, 2026 /PRNewswire/ -- Olympus Corporation of the Americas (OCA), a global MedTech company committed to advancing endoscopy-enabled care, today announced a leadership transition effective April 1, 2026, as part of a new global corporate strategy and operating......
23.03.26 - 12:01
Olympus Sells Retina Business of EyeSouth Partners (PR Newswire)
 
STAMFORD, Conn., March 23, 2026 /PRNewswire/ -- Olympus Partners has agreed to sell the retina business of EyeSouth Partners ("EyeSouth") for $1.1 billion. EyeSouth is an eye-care focused management services organization committed to partnering with leading ophthalmologists and medical......
22.03.26 - 23:49
Kalamazoo Eyes Resource Growth after Strong Gold Intercepts Below Mt Olympus Pit (Small Caps)
 
Kalamazoo Resources hits strong gold intercepts below Mt Olympus at Ashburton; 300m down-plunge, imminent resource definition to exceed 1 Moz Au....
17.03.26 - 19:09
Nvidia attackiert mit dem ARM-Serverprozessor Vera auch AMD und Intel (Heise)
 
Server-Racks mit bis zu 22.528 CPU-Kernen: Nvidias Vera-CPU mit Olympus-Kernen kommt nicht nur im Gespann mit KI-Beschleunigern auf den Markt....
11.03.26 - 15:18
Olympus Launches Next-Generation Surgical Imaging Platform in U.S. (PR Newswire)
 
The VISERA ELITE™ III Platform Was Developed by the SONY Olympus Medical Joint Venture WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ -- Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization,......
24.02.26 - 16:15
Olympus Announces Pediatric Use Indication for Two Single-Use Bronchoscopes (PR Newswire)
 
CENTER VALLEY, Pa., Feb. 24, 2026 /PRNewswire/ -- Olympus Corp. of the Americas, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, announced today FDA clearance of the pediatric use indication for two single-use bronchoscopes in the......
16.02.26 - 06:54
Olympus Corp shares slide nearly 14% on FY guidance cut (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
16.02.26 - 06:12
Japan′s Olympus shares fall over 10% as safety issues drag on (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
16.02.26 - 05:42
Olympus drops after full-year operating income forecast cut (Japan Times)
 
The Japanese medical device maker cut its outlook to between ¥75 billion and ¥87 billion, taking into account progress up to the third quarter....
13.02.26 - 19:25
Earnings call transcript: Olympus senkt Umsatzprognose – Aktie bricht ein (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
13.02.26 - 16:12
Olympus GAAP EPS of ¥12.84, revenue of ¥261.05B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.02.26 - 08:12
Olympus Corporation Nine Months Income Drops (AFX)
 
TOKYO (dpa-AFX) - Olympus Corporation (OCPNF) released a profit for nine months that Dropped, from the same period last yearThe company's earnings totaled JPY43.357 billion, or JPY38.80 per share.......
28.01.26 - 16:15
Olympus Announces U.S. Launch of the SecureFlex™ Single-Use Fine Needle Biopsy Device (PR Newswire)
 
Olympus' Newest Needle for Endoscopic Ultrasound-Guided Biopsy is Designed to Offer Precision Sampling When Access Matters Most CENTER VALLEY, Pa., Jan. 28, 2026 /PRNewswire/ -- Olympus Corp. of the Americas, a global MedTech company committed to making people's lives healthier, safer and......
15.01.26 - 03:12
Kalamazoo kicks off Mt Olympus pre-feasibility study as Ashburton drilling resumes (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
08.01.26 - 15:18
RQM+ Appoints Ross D. Segan, MD, MBA, FACS, to Board of Directors (Business Wire)
 
Former FDA and Johnson & Johnson leader brings deep clinical, regulatory, and enterprise strategy expertise to “The MedTech CRO.”PITTSBURGH--(BUSINESS WIRE)--#BoardOfDirectors--RQM+, a leading global MedTech service provider (CRO), today announced that Ross D. Segan, M.D., MBA, FACS, has joined its board of directors. Dr. Segan is a physician–executive and MedTech strategist with senior leadership experience at the U.S. Food and Drug Administration (FDA), Johnson & Johnson, Olympus, Covidien, and Vensana Capital, and currently serves as CEO of Medical Scientific Advisors, LLC. “Dr. Segan's leadership at the intersection of clinical practice, regulatory science, and global MedTech innovation is unmatched,” said John Potthoff, Ph.D., chief executive officer of RQM+. “His experience advising regulators, industry leaders, and investors will strengthen RQM+'s ability to help clients navigate complexity and deliver high-impact products to market.” “RQM+'s clear sense of purpose and respect fo...
06.01.26 - 19:39
PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market (PR Newswire)
 
GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines, today announced the acquisition of Nivagen Pharmaceuticals, Inc. ("Nivagen"),......
05.01.26 - 14:09
SageSure Completes Acquisition of Mass-Affluent Homeowners Focused Olympus (Business Wire)
 
Acquisition supports SageSure's Florida growth strategy and mass-affluent focus.JERSEY CITY, N.J.--(BUSINESS WIRE)--SageSure, the largest residential property MGU in the US specializing in catastrophe-exposed markets, announced today that it has completed the acquisition of Gemini Financial Holdings Corporation (“Gemini Financial”) and its Olympus subsidiaries (“Olympus”), one of the leading underwriting franchises in Florida. The transaction was originally announced on September 10, 2025, and closed on January 2, 2026. As part of the transaction, Valence Insurance Holdings, the parent company of SageSure's carrier partners Auros and Interboro Insurance, has acquired Olympus Insurance Company. “SageSure is proud to join forces with Olympus and build on its success in the Florida admitted homeowners market,” said Terrence McLean, President and CEO of SageSure. “This milestone enables our businesses to leverage complementary capabilities and drive growth in the mass affluent homeowners segme...
15.12.25 - 09:36
PRAGMATIC PLAY STRIKES GOLD WITH FORTUNE OF OLYMPUS (PR Newswire)
 
GIBRALTAR, 15th December 2025 /PRNewswire/-- Pragmatic Play, a leading content supplier to the iGaming industry, unleashes a thunderous new entry in its iconic Greek Gods series with Fortune of Olympus – an electrifying 7x7 cluster-pays slot charged with random multipliers, dynamic......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Frauen bewundern einen Mann wegen seiner Stärke, aber sie lieben ihn wegen seiner Schwächen. - Beatrice Brown
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!